Pharmaceuticals & Biotech|Product Engineering

Novo Nordisk
Clinical trial research

Silos forced teams to manually chase data. Now, AI agents identify adverse events in seconds, eliminating weeks of cross-referencing.

PublishedJan 4, 2026|1 month ago

Key results

Projected New Value
$157M+
Projected Efficiency
$14M+

Result highlights

Unlock 3 result highlights

The story

A century-old global pharmaceutical leader focused on diabetes and chronic diseases, managing billions of clinical trial data points across highly regulated environments.

A "patchwork spiderweb" of siloed systems forced teams to manually pass information between departments, creating bottlenecks in clinical trial...

Unlock full story

Quotes

Unlock 11 more quotes

The company

Novo Nordisk logo

Novo Nordisk

novonordisk.com

Pharmaceutical company specializing in diabetes, obesity, and rare blood disorders.

IndustryPharmaceuticals & Biotech
LocationBagsværd, Denmark
Employees50K-100K
Founded1923

Scope & timeline

  • 9 months from concept to MVP
  • 1,000 active users on data platform
  • 20% developer adoption of clinical data

Explore similar

Find AI opportunities for your
business context

Understand what's working with 2,776 recent AI case studies across industries. We structure things so you can find high-impact strategies for your exact context.

Graphic placeholder

Industries covered